BioNTech Surges On Summit's Coattails. But Can They Take On Merck?
BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment. The post BioNTech Surges On Summit's Coattails. But Can They Take On Merck? appeared first on Investor's Business Daily.
BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.
The post BioNTech Surges On Summit's Coattails. But Can They Take On Merck? appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
